Dennis Podlesak - 05 Oct 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
05 Oct 2021
Net transactions value
$0
Form type
4
Filing time
06 Oct 2021, 16:09:07 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Other $0 +463 +1.1% $0.000000 43,763 05 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock of the Issuer received from One Palmer Square Associates VIII, L.L.C. through a pro-rata distribution for no consideration.